National Surveys Reveal Differing Perceptions Among HIV-Positive Patients and Physicians About HIV and Its Treatment
Posted on: Friday, 19 May 2006, 12:10 CDT
CHICAGO, May 19 /PRNewswire/ -- According to results of national surveys released today in the Journal of the International Association of Physicians in AIDS Care (JIAPAC), 95 percent of HIV-treating physicians surveyed said they believe half or fewer of their patients "typically understand" what they are told about HIV and its treatment. In contrast, 66 percent of patients surveyed reported they "almost always" understand their conversations with physicians.
These and other gaps in perception were revealed in the peer-reviewed article, "State of HIV Treatment: Results of IAPAC Surveys of HIV-Positive Patients and HIV-Treating Physicians in the United States," which examined the attitudes of more than 500 HIV-positive patients and HIV-treating physicians regarding satisfaction with current treatment options, treatment side effects, patient-physician relationships, and several other aspects related to HIV treatment.
"While the surveys highlighted many similar views between physicians and patients on issues such as treatment goals and satisfaction with currently available antiretroviral drugs, it is clear that more candid dialogue is needed to ensure a satisfactory treatment experience for people living with HIV/AIDS," said Jose M. Zuniga, IAPAC President/CEO and the author of the JIAPAC article. "In particular, the surveys uncovered a need for greater understanding between physicians and patients on the importance of looking healthy, the significance of adherence to treatment regimens, the incidence of side effects, and estimates of patient understanding of HIV and its treatment."
Treatment Objectives and Satisfaction
The surveys indicated that a majority (79 percent) of physicians and on- treatment patients (79 percent) are "somewhat" or "very" satisfied with current treatment regimens. Most physicians surveyed also agreed that the positives of current treatments outweigh the negatives, with 72 percent indicating they "agree" or "strongly agree" that with current treatments, it is reasonable to expect that HIV-positive patients will live a normally long life. Five percent of physicians agreed that the side effects of HIV treatments were worse than the disease itself. Patients expressed less certainty on these issues than physicians, with 59 percent "agreeing" or "strongly agreeing" that they expect to live a normally long life, and 23 percent "agreeing" or "strongly agreeing" that the side effects of treatment were worse than the disease itself.
The surveys also uncovered differences of opinions between patients and physicians about various goals of treatment. For example, 60 percent of on- treatment patients and 64 percent of off-treatment patients rated "looking healthy" as an extremely important goal of treatment. In comparison, 14 percent of physicians rated keeping patients "looking healthy" as an extremely important goal. Patients and physicians shared similar views on other goals of treatment, such as viral suppression, with 68 percent of on-treatment patients and 69 percent of physicians ranking "keeping viral load as low as possible" as an extremely important goal of treatment.
Initiating Treatment
In determining when to start newly diagnosed patients on treatment, physicians said they decided to delay treatment an average of 39 percent of the time. However, patients appeared to express more reluctance about beginning treatment than physicians reported. While 39 percent of on-treatment patients said they were reluctant to begin treatment, physicians estimated an average of 15 percent of their patients were reluctant to begin treatment.
Side Effects
According to the surveys, the types and incidence of side effects varied from the patient perspective and physician perspective, with more patients reporting experiencing side effects than physicians reported. The three most common side effects patients reported experiencing were fatigue (77 percent), sleep disturbance (73 percent), and depression or anxiety (69 percent). The most common side effects reported by physicians in their patients were increased lipid levels (32 percent of physicians reported their patients were experiencing), gastrointestinal problems (27 percent), body shape changes (26 percent) and fatigue (26 percent).
According to the surveys, the gaps between patient and physician-reported incidence of side effects were largest for sleep disturbances (73 percent of patients reported experiencing versus 20 percent of physicians who reported their patients were experiencing), fatigue (77 percent of patients versus 26 percent of physicians), and joint or muscle pain (63 percent of patients versus 11 percent of physicians).
Adherence
The surveys indicated that 88 percent of physicians considered a patient to be adherent if the patient takes his or her medication at least 90 percent of the time. Physicians participating in the survey estimated that an average of 71 percent of their own patients were adherent.
In comparison, 84 percent of patients currently on treatment indicated they considered themselves adherent when it comes to taking their medication; however, 76 percent of all on-treatment patients said they took their full dosage of medication in the seven days leading up to the survey.
Physician-Patient Relations
Findings from the surveys indicated that patients and physicians hold differing perceptions of their relationships with each other. While 65 percent of patients reported having an equal partnership with their physician when making treatment decisions, 44 percent of physicians reported an equal partnership, and 47 percent of physicians said they make most of the treatment decisions on their own.
Opinions on the content and frequency of conversations between physicians and patients also varied. For example, fewer patients than physicians reported physicians discussing some important issues related to HIV treatments "very often" or "all the time," such as diet and physical exercise (53 percent of patients versus 78 percent of physicians), and safer sex (40 percent of patients versus 73 percent of physicians).
Despite these differences, the surveys pointed out that both patients and physicians agreed that physicians listen and take into consideration patients' expressed treatment objectives (71 percent of patients reported their doctor "very often" or "always" asks for and listens to their opinions, and 77 percent of physicians reported taking into account patients' treatment objectives "a great deal").
About the Surveys
A total of 152 physicians and 399 HIV-positive patients participated in the IAPAC State of HIV Treatment Survey.
Physician participants were recruited nationally, and all had been treating HIV patients for at least two years at the time of the surveys, with 16 years being the average length of time. Patient participants were recruited via a national online provider panel and through clinics and AIDS service organizations nationwide. Of patient participants, 80 percent were currently taking medications for HIV, 11 percent were currently off-treatment but had been on treatment previously, and the remaining nine percent were treatment naive.
The IAPAC State of HIV Treatment Surveys was conducted in partnership with, and through funding provided by, Bristol-Myers Squibb, and administered by Richard Day Research. An executive summary providing complete survey results may be downloaded from the IAPAC website at http://www.iapac.org/ .
Media: Jeff Danielski Matt Miller IAPAC GolinHarris Tel: (312) 795-4991 Tel: (312) 729-4463 jdanielski@iapac.org mmiller@golinharris.com
International Association of Physicians in AIDS Care (IAPAC)
CONTACT: Jeff Danielski, IAPAC, +1-312-795-4991, or jdanielski@iapac.org;or Matt Miller, GolinHarris, +1-312-729-4463, or mmiller@golinharris.com
Web site: http://www.iapac.org/
Source: PRNewswire
Related Articles
- Patients More Satisfied When Doctors Explain Certain Side Effects
- Cancer Patients And Doctors Report Drug Side Effects Differently
- More Than Half of Nurses Have Stopped or Delayed Patients' Chemotherapy Treatment, New Survey Shows
- Most Unaware FDA Tracks Drug Side Effects
- Consumer Reports Poll: Most Say TV Drug Ads Should Include Info on How to Report Side Effects
- Diabetes Drug Side Effect Reports Triple
- Genomas Announces Physiogenomic Study That Reveals Potential Cause of Metabolic Side Effects in Patients Treated With Psychotropic Drugs
- Cancer Device May Stop Side-Effects
- Diabetes Patients Report Drug Side Effects
- Modified Cancer Therapy Regimens Offer Successful Treatments for Lymphoma With Few Side Effects
User Comments (0)

RSS Feeds